KDR Biotech markets DASGIP Parallel Bioreactor Systems in Korea
Chung, Youn-Taek, Managing Director of KDR Biotech, appreciates the partnership with DASGIP. “By including the DASGIP products into our portfolio we are aiming at winning first class labs in the areas of screening, strain and cell line development as well as process development as new customers”, states Chung, Youn-Taek.
Since 2007 DASGIP has been working on its expansion towards the Asian market. CEO Thomas Drescher points out: “With SCRUM, Tokyo, and Quintech, Singapore, we already are well represented in Japan and Singapore. Now we are happy to have found a reliable partner to enter the Korean market as well”.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.